Therapeutic Areas: Oncology | Pediatrics/Neonatology | Neurology

Neuroblastoma Clinical Trials

A listing of Neuroblastoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

Arizona

Phoenix Arizona 85016-7710

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Arkansas

Little Rock Arkansas 72202

A clinical research study of Guided Therapy

Little Rock Arkansas 72202

A clinical trial seeking patients for a research study for the treatment of Relapsed or Refractory Medulloblastoma

Little Rock Arkansas 72202

A Phase 1 clinical study for patients with Neuroblastoma

Little Rock Arkansas 72202

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

California

Los Angeles California 90027

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

San Diego California 92123

A clinical research study of Guided Therapy

San Diego California 92123

A Phase 1 clinical study for patients with Neuroblastoma

San Diego California 92123

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

San Diego California 92123

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

San Francisco California

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

San Francisco California 94143

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Colorado

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Connecticut

Hartford Connecticut 06106

A clinical research study of Guided Therapy

Hartford Connecticut 06106

A Phase 1 clinical study for patients with Neuroblastoma

Hartford Connecticut 06106

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Florida

Orlando Florida 32806

A clinical research study of Guided Therapy

Orlando Florida 32806

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Georgia

Memorial University Medical Center
Savannah Georgia 31404

ACNS0821:Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

Atlanta Georgia 30322

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Hawaii

Honolulu Hawaii 96813

A clinical research study of Guided Therapy

Honolulu Hawaii 96813

A Phase 1 clinical study for patients with Neuroblastoma

Honolulu Hawaii 96813

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Illinois

Chicago Illinois 60637

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

Maryland

Baltimore Maryland 21287

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

Baltimore Maryland 21231

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Massachusetts

Boston Massachusetts 02115

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Boston Massachusetts 02115

A clinical trial to evaluate treatments using CUDC-907 for patients with Lymphoma, Neuroblastoma, Brain Tumor or Solid Tumor

Boston Massachusetts 02215

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Boston Massachusetts 02111

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Michigan

Grand Rapids Michigan 49503

A clinical research study of Guided Therapy

Grand Rapids Michigan 49503

A clinical trial seeking patients for a research study for the treatment of Relapsed or Refractory Medulloblastoma

Grand Rapids Michigan 49503

A Phase 1 clinical study for patients with Neuroblastoma

Grand Rapids Michigan 49503

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Minnesota

Minneapolis Minnesota 55404

A clinical research study of Guided Therapy

Minneapolis Minnesota 55455

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

Minneapolis Minnesota 55404

A Phase 1 clinical study for patients with Neuroblastoma

Minneapolis Minnesota 55404

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Missouri

Kansas City Missouri 64108

A clinical research study of Guided Therapy

Kansas City Missouri 64108

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

St. Louis Missouri 63104

A clinical research study of Guided Therapy

St. Louis Missouri 63104

A Phase 1 clinical study for patients with Neuroblastoma

St. Louis Missouri 63104

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

New York

Bronx New York 10467

A clinical trial seeking patients for a research study of Aromatherapy Scented Wand and Placebo wand

New York New York 10065

A clinical research study of Trametinib and Dabrafenib for the treatment of Cancer

New York New York 10032

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

New York New York 10032

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients